Pricing Log in Create free account

Promis Neurosciences (PMN) vs Veru Inc. (VERU)

Promis Neurosciences and Veru Inc. are both Biotechnology companies. Promis Neurosciences and Veru Inc. are of similar size ($35.1M and $32.7M). Promis Neurosciences grew revenue faster over the last twelve months: 450.0% against 14.2%. Across the 13 metrics below, Veru Inc. leads on 7 and Promis Neurosciences on 6.

Valuation

Metric PMN VERU Biotechnology median
P/E n/m n/m 10.60
P/S 16,913.44 2.65 9.40
P/B 0.75 1.74 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.28 n/m 0.66
EV/Sales (5,572.97) 1.44 9.02
Earnings yield (324.53%) (27.13%) (32.88%)
Free cash flow yield (113.16%) (52.80%) (23.13%)

Profitability

Metric PMN VERU Biotechnology median
Gross margin 0.00% 43.39% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (172.30%) (62.25%) (51.96%)
Return on assets (127.57%) (42.29%) (46.06%)
Return on invested capital 0.00% (464.03%) 0.00%

Growth

Metric PMN VERU Biotechnology median
Revenue growth (TTM) 450.00% 14.18% 6.76%
EPS growth (last fiscal year) (922.18%) 44.64% 29.88%
Revenue growth, 5-year CAGR — (11.89%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PMN VERU Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.85 4.42 4.97
Net debt to EBITDA 0.15 0.74 1.01

Dividend

Metric PMN VERU Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PMN VERU Biotechnology median
Market cap 32.74m 35.12m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack